Resource Center: Regulations

8 results

Search Results

Listing of State Agencies and Organizations

Description: 
A listing of websites and other contact information for state agencies that regulate substance dependence treatment. Many provide resources to assist patients or physicians in identifying treatment providers.


0
Your rating: None
Tags:
How to Prepare for a Visit from the Drug Enforcement Agency (DEA) Regarding Buprenorphine Prescribing
Description: 
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source: 
PCSS
0
Your rating: None
Tags:
Provider HIPAA Readiness Checklist
Description: 
Informational checklist designed to aid health care providers in making sure their practice is compliant with HIPAA regulations.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
4
Your rating: None Average: 4 (3 votes)
Tags:
PCSS-B Guidance: Drug Enforcement Administration Requirements for Prescribers and Dispensers of Buprenorphine and Buprenorphine/Naloxone
Description: 
This clinical guidance provides information about the requirements for storing, dispensing, and maintaining records for physicians who provide office-based opioid treatment.
Source: 
Physician Clinical Support System (PCSS)
0
Your rating: None
Tags:
Know Your Rights
Description: 
Guidance on the legal rights of individuals with alcohol and drug problems to help patients understand how they are protected from discrimination.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
4
Your rating: None Average: 4 (2 votes)
Tags:
Practitioner's Manual: An Informational Outline of the Controlled Substances Act
Description: 
Manual written by the DEA to assist physicians in understanding and complying with the Federal Controlled Substances Act. Topics covered include recordkeeping requirements, rules regarding prescription, and security requirements.
Source: 
US Drug Enforcement Administration (DEA)
4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for Maintenance and Detoxification Treatment
Description: 
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators
Description: 
This report by SAMHSA addresses the issues of buprenorphine diversion and abuse of which have developed in recent years. The report gives a summary of the findings on diversion and abuse and recommendations for the future.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags: